explore -WSS

explore

author：Wikipedia 2025-09-06 02:17:39 Page View：475

HHS 2020 — PhRMA is suing the Biden administration over its new Medicare drug price negotiation program. Graeme Sloan/Sipa USA

WASHINGTON — After losing the drug pricing fight on Capitol Hill, PhRMA is taking its battle to the courts.

The pharmaceutical industry’s biggest lobbying group on Wednesday filed a long-expected lawsuit challenging Democrats’ drug pricing law that allowed Medicare to start negotiating prices for certain medicines.

PhRMA joins a growing club of companies and trades challenging the law. Merck, Bristol Myers Squibb, and the Chamber of Commerce have already filed similar suits in different courts.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Illinois to ban advertising for guns allegedly marketed to kids and militants
Next article： Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

knowledge

As demand for Covid shots wanes, Moderna seeks its next success

RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

CDC recommends RSV monoclonal antibody for infants

Beyfortus,anewRSVmonoclonalantibodySanofiApanelofadviserstotheCentersforDiseaseControlandPreventionu

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

Arizona Democrat to raise extreme heat with Biden 1 year out from Senate primary

1:29Rep.RubenGallego,D-Ariz.,holdsatownhallinBuckeye,Ariz.,Aug.6,ashecampaignsfortheU.S.Senate.ABCNe